London-based GenAI unicorn Synthesia secures €174.5M at €2B valuation: Know more
On Wednesday, London-based Synthesia, an AI video creation platform, announced that it has secured a $180M (approximately €174.5M) Series D…
Business
The economy of building technology — markets, startups, capital flows, and the operating decisions behind ambitious companies.
8,429 articles · Business
German health and fintech company Nelly secures €50M from Cathay Innovation, Notion Capital, others
On Wednesday, Berlin-based Nelly, a health and fintech company, announced that it has raised €50M in a Series B funding round co-led by Cathay Innovation and Notion Capital.
French firm Bioptimus bags €74M to build the ‘GPT of biology’ that simulates biology instead of generating text
Paris-based Bioptimus, a company building the first universal AI foundation model for biology, on Tuesday announced that it has secured $76M (approximately €74M) in funding.
Eindhoven-based PHOTON IP secures €4.75M to advance integrated photonics: Here’s how
Eindhoven-based PHOTON IP, a manufacturer of advanced low-power optical chips, announced that it has secured €4.75M seed round led by Innovation Industries.
Adriaan Mol, Mollie CEO Koen Köppen, and YC back this new AI startup: Know more
On Monday, Delaware, US-based Open.cx, the next-generation AI customer support platform, announced that it has raised $1.52M (approximately €1.48M) in a pre-seed funding round.
In other news this week: Coave Therapeutics secures €32M, Deciphex raises €31.4M funding, Druid Software bags €19.5M and more
Technology is ever-evolving, and in this fast-paced world, it’s challenging to cover every story.
Swiss-based CeQur raises €116.4M to simplify mealtime insulin delivery for people with diabetes: Here’s how
Horw, Switzerland-based CeQur, a medical device company dedicated to simplifying mealtime insulin delivery for individuals, announced that it has secured $120M (approximately €116.4M) in the financing round.
Amsterdam-based Leyden Labs secures €68M; acquires Singapore-based CoV Biotechnology
Amsterdam-based Leyden Labs, a platform working to free people from the threat of respiratory viruses, announced Thursday that it has raised $70M (approximately €68M) in funding.
Amsterdam-based biotech company uniQure sets this share price for €73M public offering: Know more
Amsterdam-based uniQure, a biotechnology company specialising in human gene-based therapies, recently announced its public offering of 4,411,764 ordinary shares at $17.00 per share.
Austrian pet tech startup HelloBello secures €4M to accelerate its growth in Germany and Switzerland
On Thursday, Wien, Austria-based HelloBello, a pet tech company that offers freshly cooked, individually tailored meals, announced that it has secured €4M in a Series A funding round.
London-based Verdiva Bio launches with €398.4M to challenge Ozempic’s reign in obesity treatment
On Thursday, London-based Verdiva Bio Limited, a clinical-stage biopharmaceutical company, announced its launch to focus on developing innovative therapies for obesity and other cardiometabolic disorders.
Leuven-based Capricorn Partners announces first close of its new healthcare-centric VC fund at €51M; Invest-NL invests €5M
On Friday, Leuven, Belgium-based Capricorn Partners, announced the first close of its Capricorn Health-tech Fund II at €51M to support innovative health technology startups.